IL-6 in inflammation, autoimmunity and cancer

Area of Science:

• Immunology and Molecular Biology
• Cellular Biology and Disease Mechanisms

Background:

• Interleukin-6 (IL-6) is a key cytokine involved in immune responses, inflammation, hematopoiesis, bone metabolism, and embryonic development.
• Dysregulated IL-6 activity contributes to chronic inflammatory diseases, autoimmune diseases, cancer, and the cytokine storm observed in COVID-19.
• Both immune and non-immune cells, along with signaling pathways like NF-κB and STAT3, are central to inflammatory processes.

Purpose of the Study:

• To elucidate the role of the IL-6 amplifier (IL-6 Amp) in the initiation and progression of diseases.
• To investigate the synergistic interactions between NF-κB and STAT3 pathways in driving inflammation.
• To highlight the IL-6-STAT3 axis as a potential therapeutic target.

Main Methods:

• Analysis of molecular pathways involving IL-6, NF-κB, and STAT3.
• Investigation of the positive feedback loop mechanism termed the IL-6 amplifier (IL-6 Amp).
• Examination of the local initiation model for disease pathogenesis.

Main Results:

• Synergistic activation of NF-κB and STAT3 leads to hyper-activation of NF-κB and subsequent inflammatory cytokine production.
• The IL-6-STAT3 axis forms a positive feedback loop, the IL-6 Amp, which amplifies NF-κB activation.
• The IL-6 Amp is activated by diverse local initiators, supporting the local initiation model of disease.

Conclusions:

• The IL-6 amplifier (IL-6 Amp) is a critical mechanism in the local initiation of diseases driven by uncontrolled inflammation.
• The IL-6-STAT3 axis plays a pivotal role in this positive feedback loop.
• Targeting the IL-6-STAT3 axis presents a promising therapeutic strategy for a range of IL-6-mediated diseases.